Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2057909
Max Phase: Preclinical
Molecular Formula: C20H27N3O6S
Molecular Weight: 437.52
Molecule Type: Small molecule
Associated Items:
ID: ALA2057909
Max Phase: Preclinical
Molecular Formula: C20H27N3O6S
Molecular Weight: 437.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H](NS(=O)(=O)CCCOCn1ccc(=O)[nH]c1=O)c1cccc(OCC2CC2)c1
Standard InChI: InChI=1S/C20H27N3O6S/c1-15(17-4-2-5-18(12-17)29-13-16-6-7-16)22-30(26,27)11-3-10-28-14-23-9-8-19(24)21-20(23)25/h2,4-5,8-9,12,15-16,22H,3,6-7,10-11,13-14H2,1H3,(H,21,24,25)/t15-/m1/s1
Standard InChI Key: RUTIJDIFSWFFMD-OAHLLOKOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 437.52 | Molecular Weight (Monoisotopic): 437.1621 | AlogP: 1.37 | #Rotatable Bonds: 12 |
Polar Surface Area: 119.49 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.69 | CX Basic pKa: | CX LogP: 0.92 | CX LogD: 0.92 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.48 | Np Likeness Score: -1.20 |
1. Miyahara S, Miyakoshi H, Yokogawa T, Chong KT, Taguchi J, Muto T, Endoh K, Yano W, Wakasa T, Ueno H, Takao Y, Fujioka A, Hashimoto A, Itou K, Yamamura K, Nomura M, Nagasawa H, Shuto S, Fukuoka M.. (2012) Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitors., 55 (7): [PMID:22339362] [10.1021/jm201628y] |
2. Miyahara S, Miyakoshi H, Yokogawa T, Chong KT, Taguchi J, Muto T, Endoh K, Yano W, Wakasa T, Ueno H, Takao Y, Fujioka A, Hashimoto A, Itou K, Yamamura K, Nomura M, Nagasawa H, Shuto S, Fukuoka M.. (2012) Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategy., 55 (11): [PMID:22607122] [10.1021/jm300416h] |
3. (2013) Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity, |
4. (2014) Anti-tumor effect potentiator, |
Source(2):